All Content Outsourced Pharma

  1. Just – Evotec Biologics Enters Project Agreement With BARDA To Optimize Biomanufacturing Of Antibodies Against Ebola And Related Viruses 3/23/2026

    Evotec SE today announced its Seattle-based subsidiary and CDMO, Just – Evotec Biologics, Inc., has been selected by the Biomedical Advanced Research and Development Authority (BARDA) Biopharmaceutical Manufacturing Preparedness Consortium (BioMaP-Consortium) to advance manufacturing optimization for a monoclonal antibody cocktail targeting filovirus diseases, including Ebola virus (EBOV) and Sudan virus (SUDV).

  2. Generative AI Can Write The Code, But Who Builds In The Quality? 3/23/2026

    Code democratization demands a return to the fundamentals of quality in pharmaceutical and regulated environments.

  3. Overcoming Food Effects, Variability, Solubility For A Non-Opioid Analgesic With Lipid-Based Formulations 3/20/2026

    Develop optimized lipid-based formulations to overcome solubility, stability, and food-effect challenges, enabling high-dose oral delivery and rapid progression to Phase 1 trials.

  4. Overcoming API Constraints And Tight Timelines With On-Demand Manufacturing 3/20/2026

    Use innovative lipid-based formulations and on-demand manufacturing to accelerate Phase 1 trials, enable flexible dose escalation, and maximize limited API for poorly soluble compounds.

  5. Formulation Strategies For Enhancing Bioavailability Of Challenging bRo5 Molecules 3/20/2026

    Leverage mechanistic, material-sparing formulation strategies to enhance bioavailability and accelerate development of challenging bRo5 small molecules, even with limited resources.

     

  6. Leveraging Softgel To Extend Vinorelbine's Lifecycle, Improve Patient Convenience 3/20/2026

    Develop innovative oral formulations of traditionally intravenous therapies to enhance patient convenience, ensure consistent systemic exposure, and support long-term brand value and market differentiation.

  7. Biocapacitance Measurement: A PAT Tool For Biomass Measurement In An Upstream Process 3/20/2026

    Leverage process analytical technologies (PAT) to gain real-time insight into product quality, strengthen control strategies, and build more efficient, scalable manufacturing processes for future success.

  8. A Cell Line Development Platform Accelerating Timelines To Clinic 3/20/2026

    To support a seamless transition from early clinical studies through to commercial manufacturing, cell line expression systems must be carefully designed and selected based on several critical attributes.

  9. Commercializing CAR T Cell Therapy With Legend Biotech's Alan Bash 3/20/2026

    On this week's episode of the Business of Biotech we're speaking with Alan Bash, President, Carvykti, at Legend Biotech, about how Carvykti became a blockbuster, category-leading CAR T therapy for multiple myeloma.

  10. Aseptic Filling Quality Through Continuous Improvement 3/20/2026

    Meet an operational excellence leader helping teams simplify workflows. His work shows how continuous refinement supports more efficient processes and more consistent outcomes.